4/29/2022 7:20:34 AM
Lantheus Holdings Q1 EPS $0.61; Adj EPS $0.97
7/28/2021 7:38:25 AM
Lantheus Holdings Q2 GAAP Net Loss $26.7 Mln Or $0.39/shr Vs. Net Loss $7.0 Mln Or $0.16/shr Last Year
5/27/2021 7:11:39 AM
Lantheus Gets FDA Approval Of PYLARIFY Injection
5/4/2021 7:31:42 AM
Lantheus Holdings Q1 Net Income $9.0 Mln Vs. $3.3 Mln Last Year
4/30/2021 8:36:44 AM
Lantheus Holdings Announces Strategic Collaboration With Allegheny Health Network
4/1/2021 8:33:28 AM
Lantheus Announces Retirement Of Michael Duffy, SVP And General Counsel
3/30/2021 8:34:28 AM
Lantheus Acquires Exclusive, Worldwide Rights To Develop,
manufacture And Commercialize NTI-1309